Sharif joined Polaris in 2018 and is an entrepreneur advisor based out of the firm’s San Francisco office. In this role, Sharif focuses on founding, building and investing in digital health and biotech companies. Sharif currently serves on the Board of Directors of two stealth portfolio companies, and as a Board Observer to Thirty Madison. Sharif is also a practicing primary care physician who sees patients at Stanford, where he is a Clinical Assistant Professor.
Prior to joining Polaris, Sharif was the cofounder of USMLE Pro, a medical education company, and worked in Business Development for RNA therapeutics company Translate Bio (acquired by Sanofi) and in Corporate Strategy roles for cell therapy companies Arcellx and Nkarta. Sharif completed his clinical training in Internal Medicine at Stanford and holds an MD from the Johns Hopkins School of Medicine, an MBA from Harvard Business School, and an MS and BS in Biology from Yale University.